Fig. 4From: Bleeding events associated with a low dose (110 mg) versus a high dose (150 mg) of dabigatran in patients treated for atrial fibrillation: a systematic review and meta-analysisBleeding events associated with 100 mg versus 150 mg dabigatran using data obtained only from randomized trialsBack to article page